![Benjamin Oakes](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Benjamin L.
Oakes is President, Chief Executive Officer, and Director at Scribe Therapeutics, Inc. Dr. Oakes is the founder of Scribe Therapeutics, Inc., founded in 2017.
Postes actifs de Benjamin Oakes
| Sociétés | Poste | Début |
|---|---|---|
Scribe Therapeutics, Inc.
 Scribe Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops CRISPR-based genetic medicines to extend healthy lifespan through disease prevention and durable therapeutic interventions | Fondateur | 01/06/2017 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
4
Relations au 1er degré
1
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Scribe Therapeutics, Inc.
Scribe Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops CRISPR-based genetic medicines to extend healthy lifespan through disease prevention and durable therapeutic interventions | Health Technology |
Choisissez Zonebourse 
